Literature DB >> 31974217

Long-term Puberty Suppression for a Nonbinary Teenager.

Ken C Pang1,2,3,4, Lauren Notini1,5, Rosalind McDougall6, Lynn Gillam6,7, Julian Savulescu1,8, Dominic Wilkinson8, Beth A Clark9, Johanna Olson-Kennedy10, Michelle M Telfer1,2, John D Lantos11.   

Abstract

Many transgender and gender-diverse people have a gender identity that does not conform to the binary categories of male or female; they have a nonbinary gender. Some nonbinary individuals are most comfortable with an androgynous gender expression. For those who have not yet fully progressed through puberty, puberty suppression with gonadotrophin-releasing hormone agonists can support an androgynous appearance. Although such treatment is shown to ameliorate the gender dysphoria and serious mental health issues commonly seen in transgender and gender-diverse young people, long-term use of puberty-suppressing medications carries physical health risks and raises various ethical dilemmas. In this Ethics Rounds, we analyze a case that raised issues about prolonged pubertal suppression for a patient with a nonbinary gender.
Copyright © 2020 by the American Academy of Pediatrics.

Entities:  

Year:  2020        PMID: 31974217     DOI: 10.1542/peds.2019-1606

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  3 in total

Review 1.  Growth, growth potential, and influences on adult height in the transgender and gender-diverse population.

Authors:  Stephanie A Roberts; Jeremi M Carswell
Journal:  Andrology       Date:  2021-06-03       Impact factor: 4.456

2.  Selective Estrogen Receptor Modulators: A Potential Option For Non-Binary Gender-Affirming Hormonal Care?

Authors:  Jane Y Xu; Michele A O'Connell; Lauren Notini; Ada S Cheung; Sav Zwickl; Ken C Pang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-18       Impact factor: 5.555

3.  Forever young? The ethics of ongoing puberty suppression for non-binary adults.

Authors:  Lauren Notini; Brian D Earp; Lynn Gillam; Rosalind J McDougall; Julian Savulescu; Michelle Telfer; Ken C Pang
Journal:  J Med Ethics       Date:  2020-07-24       Impact factor: 5.926

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.